Dolutegravir

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2863 publications

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV.

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV.

Journal: Antimicrobial agents and chemotherapy

Published: June 12, 2026

First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapy.

First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapy.

Journal: Research square

Published: June 12, 2026

HIV resistance to integrase strand-transfer inhibitors: disproportionality analysis of individual case safety reports from the WHO global safety database (VigiBase).

HIV resistance to integrase strand-transfer inhibitors: disproportionality analysis of individual case safety reports from the WHO global safety database (VigiBase).

Journal: Current medical research and opinion

Published: June 11, 2026

Uridine diphosphate glucuronosyltransferase 1A1 gene polymorphisms and treatment outcomes in HIV and MTB coinfection in sub-Saharan Africa: a scoping review protocol.

Uridine diphosphate glucuronosyltransferase 1A1 gene polymorphisms and treatment outcomes in HIV and MTB coinfection in sub-Saharan Africa: a scoping review protocol.

Journal: BMJ open

Published: June 08, 2026

Comment on: 'Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failure'.

Comment on: 'Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failure'.

Journal: The Journal of antimicrobial chemotherapy

Published: May 26, 2026

Is dose adjustment of dolutegravir necessary in Chinese adults living with HIV across different body weight levels? A population pharmacokinetics analysis.

Is dose adjustment of dolutegravir necessary in Chinese adults living with HIV across different body weight levels? A population pharmacokinetics analysis.

Journal: Expert review of clinical pharmacology

Published: May 25, 2026

Is dose adjustment of dolutegravir necessary in Chinese adults living with HIV across different body weight levels? A population pharmacokinetics analysis.

Is dose adjustment of dolutegravir necessary in Chinese adults living with HIV across different body weight levels? A population pharmacokinetics analysis.

Journal: Expert review of clinical pharmacology

Published: May 25, 2026

Use of Integrase Strand Transfer Inhibitors Among Children Living With HIV in Latin America and the Caribbean.

Use of Integrase Strand Transfer Inhibitors Among Children Living With HIV in Latin America and the Caribbean.

Journal: The Pediatric infectious disease journal

Published: May 22, 2026

Erythrovirus-B19-Induced Pure Red Cell Aplasia Revealing Untreated HIV Infection.

Erythrovirus-B19-Induced Pure Red Cell Aplasia Revealing Untreated HIV Infection.

Journal: The American journal of case reports

Published: May 19, 2026

Integrase Inhibitors: Redefining HIV-1 Treatment and Future Challenges.

Integrase Inhibitors: Redefining HIV-1 Treatment and Future Challenges.

Journal: Missouri medicine

Published: May 13, 2026

Pharmacogenomics of current antiretroviral drugs.

Pharmacogenomics of current antiretroviral drugs.

Journal: Pharmacogenomics

Published: May 12, 2026

The role of dolutegravir on therapy of HTLV-1 infection.

The role of dolutegravir on therapy of HTLV-1 infection.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: April 30, 2026

Showing 1-12 of 2,863

Last Updated: 06/30/2026